Download Hematology/Oncology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Clinical trial wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Electronic prescribing wikipedia , lookup

Theralizumab wikipedia , lookup

Biosimilar wikipedia , lookup

Bad Pharma wikipedia , lookup

Transcript
EXPECT EXCELLENCE
Hematology/Oncology
• Rapidly develop and implement local and global
• Global project management organization
strategies for your hematology/oncology program with
• Global regulatory support services
our feasibility and global drug development teams
• Late-stage research services, including Phase IIIb/
supported and led by board-certified oncologists
IV studies, pharmacoepidemiology, risk management, • Obtain quality data to enable successful submissions
observational studies and registries
from a contract research organization with a proven
• Integrated medical imaging solutions through our record of project and program success
strategic partnership with VirtualScopics
• Gain immediate access to a deep bench of experienced
Hematology/Oncology Study Experience
hematology/oncology resources across the globe
(Past Five Years)
Global Expertise in Managing Complex Hematology/
Oncology Research
Indication Experience*
PPD holds a preeminent position as a leader in
Lung
hematology/oncology research. Our global experience in
Solid Tumors
the past five years includes more than 300 hematology
Prostate
and oncology studies involving more than 75,000 patients,
Hematology
Breast
including pediatric populations.
Leukemia
Skin
Ovary/Uterus
PPD’s cross-functional hematology/oncology team, led
Lymphoma
by senior scientists and clinicians with extensive drug
Brain
development experience, includes dedicated therapeutic
Head and Neck
trial management, medical, pharmacovigilance, regulatory,
medical writing, biostatistics and data management
Multiple Myeloma
Colorectal
professionals. From feasibility studies to protocol design
0 5 10 1520 2530 3540
* Indications for which PPD has conducted 10 or more trials
to simultaneous multinational submissions, PPD has the
global infrastructure, resources, integrated technologies
Study Phase
and commitment to quality to support your needs.
• Early stage development studies, including translational medicine, Phase 0, first in human trials in both healthy volunteers and patients, dose escalation and global cohort management adaptive design studies
• PPD® Consulting to custom design and implement an
integrated development plan to aid clients in tracking
and reaching key development milestones, while proactively managing risks
www.ppdi.com
+1 877 6 GET PPD (643 8773) U.S. & CANADA
© 2013 Pharmaceutical Product Development, LLC. All rights reserved.
+1 919 456 5600 OUTSIDE THE U.S. & CANADA
PPD Comprehensive Medical and Scientific Resources
Medical Imaging Services
• PPD® Consulting offers clients a professional team
PPD’s strategic alliance with VirtualScopics expedites
of product development experts with extensive
clients’ oncology clinical trials with best-in-class,
experience from pre-clinical to post-approval
comprehensive clinical development and medical imaging
planning
services. This unique offering provides:
• More than 3,000 professionals worldwide with • A strategically integrated approach that allows clients
experience in oncology, including more than 100 to benefit from efficiencies and make fast, confident
project managers, and 9 oncologists
decisions
• A global network of nearly 10,000 investigators with • Tailored solutions designed to meet the unique needs
experience in hematology/oncology clinical research, of each client’s oncology development program and
including many of the major cancer institutions
quickly progress their therapies from early phase to
around the globe
regulatory approval
• Member of the CEO Roundtable on Cancer,
• Seamless integration of technologies and processes,
collaborating with industry partners and the National
giving biopharmaceutical companies near real-time,
Cancer Institute to accelerate the discovery and
consistent and reliable medical imaging information
development of novel and more effective diagnostic
to expedite their drug development programs tools and anti-cancer therapies
• Ranked number one among CROs in the 2011
CenterWatch global site survey, in which 84.3% of
participants ranked PPD’s overall relationship quality
as “excellent” or “good”
Process and Technology Driven Quality
PPD has integrated training tools, quality control
processes and best practices through the full operational
lifecycle of a project to address common challenges in
oncology studies and to ensure the quality of the data our
partners use to make critical development decisions.
• Adaptive protocol designs
• Early data review and in-stream cleaning
• Radiological endpoints and tumor assessments
• Real time access to patient data listings and
• Independent review of endpoints derived datasets
using PPD® Patient Profiles
• Survival follow-up and patient retention
• Non-linear event predictions
• Patient-recorded outcomes
• Event tracking and adjudication
• Patient eligibility safeguards
• Data Safety Monitoring Board
• Local laboratory data integration and central
laboratory services
• Biosimilars Product Development practice area
www.ppdi.com
+1 877 6 GET PPD (643 8773) U.S. & CANADA
© 2013 Pharmaceutical Product Development, LLC. All rights reserved.
+1 919 456 5600 OUTSIDE THE U.S. & CANADA